Follow-up study of high-dose praziquantel therapy for cerebral sparganosis.

• Main Authors: Peng Zhang (Author), Yang Zou (Author), Feng-Xia Yu (Author), Zheng Wang (Author), Han Lv (Author), Xue-Huan Liu (Author), He-Yu Ding (Author), Ting-Ting Zhang (Author), Peng-Fei Zhao (Author), Hong-Xia Yin (Author), Zheng-Han Yang (Author), Zhen-Chang Wang (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Cerebral sparganosis is the most serious complication of human sparganosis. Currently, there is no standard for the treatment of inoperable patients. Conventional-dose praziquantel therapy is the most reported treatment. However, the therapeutic outcomes are not very e...